Presentations

A step-wise analysis of multiple biomarkers drives the development of a Semi-Mechanistic Comprehensive Model. Application to modulation of Amyloid-β

Maanen E.v., Stone J.A., Steeg T.v., Ahsman M., Savage M.J., Michener M.S. and Kleijn H., A step-wise analysis of multiple biomarkers drives the development of a Semi-Mechanistic Comprehensive Model. Application to modulation of Amyloid-β. PAGE.(2012) [Link to publication]

Data transformation procedure to improve identifiability of efficacy and potency

Maanen E.v., Ackaert O., Snelder N., Bergmann K., Maciag C., Quirk M., Wallsten C. and Ploeger B., Data transformation procedure to improve identifiability of efficacy and potency: Application to continuous elevated plus-maze data in rats., PAGE.(2012) [Link to publication]

Development of a mechanistic based model for neonatal Fc receptor recycling to design human serum albumin mutants with extended half-lives

Bergmann K., Steeg T.v., Smeets J., Chaudhury C. and Agoram B., Development of a mechanistic based model for neonatal Fc receptor recycling to design human serum albumin mutants with extended half-lives PAGE.(2012) [Link to publication]

Quantification of Antidepressant and Sedative Effect of Two NMDA Channel Blockers

Bergmann K., Ackaert O., Maanen E.v., Snelder N., Maciag C., Quirk M., Wallsten C. and Ploeger B., Quantification of Antidepressant and Sedative Effect of Two NMDA Channel Blockers, AZD6765 and Ketamine, in an Animal Model of Depression Using Count Data. PAGE.(2012)

Comparing a mechanistic with an empirical approach to assess resistance development of antibacterials in vitro

Bergmann K., Ackaert O., Haddish-Berhane N. and Betts A., Comparing a mechanistic with an empirical approach to assess resistance development of antibacterials in vitro., PAGE.(2012) [Link to publication]

Population modeling of blood pressure

Ackaert O., Rijn-Bikker P.v., Snelder N., Hest R.v., Ploeger B., Monfrans G.v., Koopmans R. and Mathot R., Population modeling of blood pressure: assessing clinically important factors for cardiovascular diseases. PAGE.(2011) [Link to publication]

Quantitative understanding of drug effects on the interrelationship between mean arterial blood pressure, cardiac output and total peripheral resistance

Snelder N., Ploeger B.A., Danhof M., Stanski D.R., Rigel D., Webb R., Feldman D. and Luttringer O., Quantitative understanding of drug effects on the interrelationship between mean arterial blood pressure, cardiac output and total peripheral resistance. PAGE.(2011) [Link to publication]

Challenges in Non-Clinical Assessment of Antisense Oligonucleotides

Maanen E.V., Challenges in Non-Clinical Assessment of Antisense Oligonucleotides: Modelling Perspectives. AAPS (National Biotechnology Conference).(2011)

A true Markov model for sleep disturbance

Diack  C., Ackaert O., Ploeger B., Graaf P.v.d., Gurrell R., Ivarsson M. and Fairman D., A true Markov model for sleep disturbance. PAGE.(2010). [Link to publication]

A novel integrated RNAi/viral dynamics systems pharmacology model

Maanen E. v., Brady K., Steeg T.v. and Graaf P.v.d., A novel integrated RNAi/viral dynamics systems pharmacology model to predict clinical efficacy of viral vector delivery of siRNA for the treatment of HCV. Noordwijkerhout.(2010)